Table 2.
One way ANOVA of frontal and parietal ERPs to targets at post-treatment stage (TMS-neurofeedback [TMS-NFB, N=20] vs. Wait-list group [N=22])
| Dependent variables | TMS-NFB Mean ± SD | Wait-list Mean ± SD | F value, df F(1,40) | Significance P value |
|---|---|---|---|---|
| Frontal & fronto-central: | ||||
| N100 amplitude (μV) | -2.62±2.52 | -3.22±3.00 | 0.14 | 0.705 |
| N100 latency (ms) | 137.3±14.0 | 122.5±18.2 | 8.75 | 0.005** |
| P2d difference wave (μV) | 0.77±4.50 | -2.11±3.66 | 5.25 | 0.027* |
| P2d wave latency (ms) | 320.5±33.5 | 335.0±49.9 | 1.20 | 0.279 |
| N200 amplitude (μV) | -201±3.95 | -2.02±3.52 | 0.93 | 0.762 |
| N200 latency (ms) | 356.15±39.9 | 300.5±35.9 | 20.72 | >0.001*** |
| P300(P3a)amplitude(μV) | 5.57±4.65 | 6.54±3.99 | 1.15 | 0.289 |
| P300(P3a) latency (ms) | 434.9±27.0 | 409.6±55 | 3.45 | 0.070 |
| Parietal & centro-parietal: | ||||
| P200 amplitude (μV) | 2.58±2.69 | 3.95±2.65 | 3.03 | 0.089 |
| P200 latency (ms) | 156.5±49.2 | 124.7±16.8 | 8.11 | 0.007*** |
| N200 amplitude (μV) | -2.66±2.81 | -2.78±3.64 | 0.016 | 0.899 |
| N200 latency (ms) | 244.1±63.6 | 201.3±24.3 | 10.39 | 0.002** |
| P300(P3b) amplitude(μV) | 2.47±4.46 | 7.57±9.40 | 4.73 | 0.035** |
| P300(P3b) latency (ms) | 375.6±56.3 | 323.7±27.9 | 16.07 | >0.001** |
| Fronto-central: | ||||
| ERN/Ne amplitude (μV) | -4.31±4.79 | -0.02±6.05 | 5.00 | 0.032* |
| ERN/Ne latency (ms) | 68.44±27.7 | 108.1±49.3 | 8.74 | 0.006** |
| Pe amplitude (μV) | 8.57±5.71 | 5.53±4.14 | 3.20 | 0.083 |
| Pe latency (ms) | 176.4±41.3 | 202.2±44.8 | 3.13 | 0.086 |
| Reaction time, accuracy: | ||||
| RT (ms) | 507.9±104.39 | 455.5±123.3 | 2.53 | 0.118 |
| Commission error (%) | 2.96±3.67 | 11.50±17.24 | 5.409 | 0.024* |
| Omission error (%) | 2.65±4.35 | 2.91±4.35 | 0.178 | 0.675 |
| Total error (%) | 5.59±7.26 | 13.71±17.95 | 4.10 | 0.048* |
| Post-error RT change (ms) | 34.95±49.9 | -13.90±33.84 | 16.39 | >0.001*** |